Osteoporosis
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Primary physiologic amenorrhea
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Small labia majora
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Elevated circulating follicle stimulating hormone level
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Elevated circulating luteinizing hormone level
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Eunuchoid habitus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
No evidence for the involvement of the human c-erb genes in neoplasia has been found.
|
6323162 |
1984 |
Cervical Intraepithelial Neoplasia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression of the oncogenes Ha-RAS, c-MYC, and ERB-2 was investigated with an automated image analysis system in 12 specimens of normal cervix, 10 of cervical intraepithelial neoplasia (CIN) grade 1, 24 of CIN 3, and 10 of invasive cancer of the cervix.
|
1672915 |
1991 |
Endometrial Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Role of DNA ploidy and ERB-B2 oncogene expression in the prognosis of endometrial carcinoma.
|
7746737 |
1994 |
Malignant neoplasm of breast
|
0.600 |
Biomarker
|
disease |
BEFREE |
Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis.
|
8616779 |
1996 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis.
|
8616779 |
1996 |
Malignant neoplasm of breast
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Expression of estrogen receptor beta messenger RNA variant in breast cancer.
|
9443393 |
1998 |
Endometriosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Using reverse transcription-polymerase chain reaction (RT-PCR), we studied the expression of oestrogen receptor-alpha splicing variants and oestrogen receptor-beta in uterine biopsies from 12 patients with endometriosis and 15 patients with unexplained infertility.
|
9701786 |
1998 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Expression of estrogen receptor beta messenger RNA variant in breast cancer.
|
9443393 |
1998 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
ER beta gene expression was not limited to ER alpha-positive tumor subtypes, however, and was also found in 100% of null cell tumors, 80% of somatotroph tumors, and 60% of corticotroph tumors.
|
9745446 |
1998 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The mapped genes include three oncogenes (Fyn, Mas1, and Vav1), a tyrosine kinase gene (Syk), a tumor-associated antigen gene (Cd24), a growth factor receptor gene (Igf2r), the gene for an activator of c-fos/c-jun transcription factors (Apex), a transcription factor gene (Egr3), and several genes involved in steroid hormone metabolism and signaling (Esr2, Pgr, Cbg, Cyp17, and Cyp19).
|
9730607 |
1998 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
However, because of its relatively close physical distance from the characteristic site of rearrangements in 14q23-24, a role for ESR2 in the pathobiology of these tumors warrants future consideration.
|
9824210 |
1998 |
Uterine Fibroids
|
0.070 |
Biomarker
|
group |
BEFREE |
Using fluorescence in situ hybridization and radiation hybrid mapping, we map ESR2 within 14q23-24.1, to a region approximately 2 Mb centromeric to the t(12;14) breakpoint in uterine leiomyomata, between markers D14S63 and WI-7536.
|
9824210 |
1998 |
Anorexia Nervosa
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We systematically screened the coding region and part of the 5' and 3'regions of the estrogen receptor beta gene (ER beta) in 96 extremely obese children and adolescents, 50 patients with anorexia nervosa (AN), 28 patients with bulimia nervosa (BN), and 25 healthy underweight individuals.
|
9851804 |
1998 |
Benign Neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
The human estrogen receptor beta gene (ESR2) has been identified recently and mapped to 14q22-24, a region frequently rearranged in uterine leiomyomata and other benign tumors, including pulmonary chondroid hamartomas and endometrial polyps.
|
9824210 |
1998 |
Hamartoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Using RT-PCR, we show that ESR2 is expressed in uterine leiomyomata and pulmonary chondroid hamartomas as well as in normal myometrium.
|
9824210 |
1998 |
Uterine Polyp
|
0.010 |
Biomarker
|
disease |
BEFREE |
The human estrogen receptor beta gene (ESR2) has been identified recently and mapped to 14q22-24, a region frequently rearranged in uterine leiomyomata and other benign tumors, including pulmonary chondroid hamartomas and endometrial polyps.
|
9824210 |
1998 |
Bulimia Nervosa
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We systematically screened the coding region and part of the 5' and 3'regions of the estrogen receptor beta gene (ER beta) in 96 extremely obese children and adolescents, 50 patients with anorexia nervosa (AN), 28 patients with bulimia nervosa (BN), and 25 healthy underweight individuals.
|
9851804 |
1998 |